Zobrazeno 1 - 10
of 15
pro vyhledávání: '"MAJLINDA XHIKOLA"'
Publikováno v:
Journal of Clinical and Translational Endocrinology Case Reports, Vol 24, Iss , Pp 100117- (2022)
Objective: Central venous migration of polymethylmethacrylate (PMMA) is a rare but potentially serious complication of percutaneous injection of PMMA performed to treat symptomatic vertebral fractures.Most emboli cases to the heart result in cardiac
Externí odkaz:
https://doaj.org/article/0f0f88e7b98c453485e9169c6164adca
Publikováno v:
JCEM Case Reports. 1
Autor:
CARLOS E. MENDEZ, ELIZABETH A. MATTOX, SUSHMA KADIYALA, MAJLINDA XHIKOLA, KONSTANTINA YANTSIDES, ANGELA D. OIEN, IRENE O'SHAUGHNESSY, ANN E. HANSEN, JESSICA LUCAS, KYLE HAZEN, LUZ M. SEMEAH, JULIO A. LEEY
Publikováno v:
Diabetes. 71
Access to specialized diabetes care is limited due to shortage of endocrinologists and distance to specialty clinics. In addition, referrals to out-of-network providers frequently results in suboptimal care coordination. Tele-mentoring models such as
Publikováno v:
Journal of the Endocrine Society. 6:A180-A181
Introduction Zoledronic acid, used for treatment of osteoporosis, Paget's disease of the bone, hypercalcemia of malignancy etc. is a bisphosphonate known for its anti-resorptive effect. A common adverse reaction with this medication is mild to modera
Publikováno v:
Journal of the Endocrine Society. 6:A563-A563
Introduction/Background Galactorrhea in men is rare, with a reported prevalence of 5.5%. It tends to occur bilaterally rather than unilaterally. Among the etiologies of galactorrhea, pharmacologic agents, pituitary tumors, and hypothalamic and pituit
Publikováno v:
Journal of the Endocrine Society. 6:A161-A161
Introduction Denosumab is a receptor activator of nuclear factor kappa-B (RANK) ligand inhibitor used for treatment of osteoporosis and bone metastases in patients with solid tumors. Denosumab induced hypophosphatemia has been reported in less than 1
Publikováno v:
Journal of the Endocrine Society. 6:A257-A257
Background Carnitine Palmitoyltransferase II deficiency (CPT II) is a disorder of long-chain fatty-acid oxidation. Clinical presentations include a lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form. The myopathic fo
Autor:
Majlinda Xhikola, Anand Vaidya, Irina Bancos, Dingfeng Li, Tiffany Abbondanza, Natalia Genere, Emma Behnken
Publikováno v:
J Clin Endocrinol Metab
Context Current evidence on determinants of adverse health outcomes in patients with adrenal insufficiency (AI) is scarce, especially in regards to AI subtypes. Objective To determine predictors of adverse outcomes in different subtypes of AI. Design
Autor:
Anand Vaidya, Majlinda Xhikola, Irina Bancos, Dingfeng Li, Tiffany Abbondanza, Natalia Genere, Emma Behnken
Publikováno v:
Journal of the Endocrine Society
Background: Patients with primary adrenal insufficiency (PAI) and secondary adrenal insufficiency (SAI) report impaired quality of life. Predictors of adverse outcomes include duration of disease, supraphysiologic glucocorticoid (GC) use, and presenc
Autor:
Majlinda Xhikola, Dingfeng Li, Anand Vaidya, Irina Bancos, Emma Behnken, Tiffany Abbondanza, Natalia Genere
Publikováno v:
Journal of the Endocrine Society
Background: Adrenal insufficiency (AI) is a chronic disorder necessitating life-long replacement. Patients’ quality of life and health outcomes depend on knowledge and comfort level with self-management. Objective: To determine patients’ knowledg